Donald Smith & Co. Nomura Holdings Inc ADR transactions over time
NMR
Nomura Holdings Inc ADR historical holders
total: 1
Transactions details
- Total transactions:
- 8
- New positions:
- 1
- Added:
- 6
- Reduced:
- 1
- Held since:
- 2024 Q3
- Held for:
- 8 quarters
- Latest activity:
- 2026 Q2
Donald Smith & Co. has been an institutional investor in Nomura Holdings Inc ADR (NMR) since 2024 Q3. According to 2026 Q2 report, Donald Smith & Co. holds 12,211,249 shares with a market value of roughly $107.21M representing 1.90% of their equity portfolio. The fund/company first acquired NMR in 2024 Q3, initially purchasing about 6.47M shares. Since the initial investment, Donald Smith & Co. has made 7 more transactions in this position.
Does Donald Smith & Co. still hold NMR?
Yes, Donald Smith & Co. continues to hold Nomura Holdings Inc ADR (NMR). According to their 2026 Q2 report, they maintain a position of 12,211,249 shares valued at approximately $107.21M, representing 1.90% of their equity portfolio.
When did Donald Smith & Co. first invest in NMR?
Donald Smith & Co. first invested in Nomura Holdings Inc ADR (NMR) in 2024 Q3 at the reported quarter-end price of $5.22 per share, acquiring 6,471,782 shares in their initial purchase.
What is Donald Smith & Co.'s average cost basis for NMR?
Based on historical transaction data, Donald Smith & Co.'s estimated cost basis for Nomura Holdings Inc ADR (NMR) is approximately $5.86 per share. This represents their average reported price* across all buy transactions.
Estimated cost basis*
- Weighted AVG buy price:
- $5.86
- Weighted AVG sell price:
- $8.78
NMR transactions history by Donald Smith & Co.
8 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2026 Q2
|
1.90%
|
12,211,249
|
$8.78
|
$107,214,766
|
-7.28% (-958,244)
|
-0.15%
|
|
2026 Q1
|
1.87%
|
13,169,493
|
$7.89
|
$103,907,300
|
+3.73% (+473,959)
|
+0.07%
|
|
2025 Q4
|
2.00%
|
12,695,534
|
$8.39
|
$106,515,530
|
+2.21% (+274,787)
|
+0.04%
|
|
2025 Q3
|
1.80%
|
12,420,747
|
$7.27
|
$90,298,831
|
+12.27% (+1,357,311)
|
+0.2%
|
|
2025 Q2
|
1.71%
|
11,063,436
|
$6.58
|
$72,797,409
|
+6.25% (+650,835)
|
+0.1%
|
|
2025 Q1
|
1.57%
|
10,412,601
|
$6.15
|
$64,037,496
|
+11.74% (+1,094,218)
|
+0.16%
|
|
2024 Q4
|
1.29%
|
9,318,383
|
$5.79
|
$53,953,438
|
+43.98% (+2,846,601)
|
+0.39%
|
|
2024 Q3
|
0.80%
|
6,471,782
|
$5.22
|
$33,782,702
|
new
|
+0.8%
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.